miltefosine has been researched along with quinoline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azas, N; Casanova, M; Castera-Ducros, C; Dumètre, A; Hutter, S; Kraiem-M'rabet, M; Laget, M; Mbatchi, L; Paloque, L; Rathelot, P; Rault, S; Remusat, V; Vanelle, P; Verhaeghe, P | 1 |
Chandrakar, P; Gupta, S; Kar, S; Kushwaha, P; Parmar, N; Rashid, M; Sashidhara, KV; Singh, SK; Upadhyay, A; Wahajuddin, M | 1 |
Arvelo, F; Benaim, G; Dagger, F; Kouznetsov, VV; Mejías, F; Rojas-Ruiz, FA; Sojo, F; Torrealba, C; Valdivieso, E | 1 |
3 other study(ies) available for miltefosine and quinoline
Article | Year |
---|---|
Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Topics: Animals; Antiprotozoal Agents; Drug Discovery; Hep G2 Cells; Humans; Leishmania donovani; Life Cycle Stages; Mice; Nitroquinolines | 2012 |
Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Disease Models, Animal; Leishmania donovani; Leishmaniasis, Visceral; Metronidazole; Quinolines; Rats; Structure-Activity Relationship; Tissue Distribution; Vero Cells | 2019 |
In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Drug Therapy, Combination; Leishmania donovani; Macrophages; Membrane Potential, Mitochondrial; Mice; Phosphorylcholine; Quinolines | 2018 |